SCHEMBL17786097

SCHEMBL17786097

NC(=O)c1cccc(C2CCCCC2=O)c1N

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PARP1 P09874 13/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2B6 P20813 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ PARP2 Q9UGN5 2/20 0.38
▸ MCL1 Q07820 1/20 0.38
▸ TP53 P04637 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9699947 0.87 MCL1 (0.44) PARP1ALOX15MAPK1CASP1CASP7
SCHEMBL15477730 0.85 MCL1 (0.43) PARP1CYP2D6CYP2B6POLBHTT
SCHEMBL11903532 0.75 KDM4E (0.41) PARP1HSD17B10CYP2D6CYP2B6PARP2
SCHEMBL30666294 0.75 KDM4E (0.39) PARP1HSD17B10PARP2KDM4EALDH1A1
SCHEMBL5968286 0.75 CREBBP (0.45) MAPK1MCL1KDM4E
SCHEMBL11081798 0.71 MCL1 (0.41) POLBMCL1KDM4EALDH1A1
SCHEMBL148615 0.70 PARP1 (0.39) PARP1ALOX15MAPK1CASP1CASP7
SCHEMBL11079196 0.70 MCL1 (0.40) MCL1KDM4EALDH1A1
SCHEMBL1514873 0.70 HPD (0.44) CASP1HSD17B10KDM4EALDH1A1
SCHEMBL7866000 0.70 MEN1 (0.46) ALOX15HTTMCL1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016086153-A2 USE OF TETRAHYDRO!NDAZOLYLBEIMZAMIDE AND TETRAHYDROINDOLYLBENZAMIDE DERIVATIVES FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS) ESANEX, INC. (US) 2016-06-02 — — WO disclosed
Send feedback